We are live on ! Find out more
STJ

St Jude Medical
STJ

Delisted

STJ was delisted on the 4th of January, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in St Jude Medical in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $6K → $0 (-$6K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
AIM
Advantage Investment Management
Iowa
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
Advantage Investment Management
Iowa
– -$6K -100 Closed

STJ Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q4 2017, worth a combined $0 — down 100% from $6K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of STJ and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Advantage Investment Management, exiting entirely with an estimated $6K sold.

  • 0 institutional investors held St Jude Medical (STJ) as of Q4 2017, down from 1 in Q3 2017.
  • Funds reported $0 of St Jude Medical stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new St Jude Medical positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest St Jude Medical seller in Q4 2017 was Advantage Investment Management, an estimated $6K sold.

Based on aggregated 13F filings for Q4 2017.